Allen Steere

Bay Area Lyme Foundation Partners with American Junior Golf Association to Provide Critical Education About Tick-borne Disease

Retrieved on:

Thursday, July 15, 2021

Bacterial diseases, Tick-borne diseases, Medicine, Medical specialties, Lyme disease, Chronic Lyme disease, Health fraud, Bacteriology, Lyme, Connecticut, Tick-Borne Disease Alliance, Allen Steere

PORTOLA VALLEY, Calif., July 15, 2021 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, and the American Junior Golf Association have announced a new partnership aimed at educating young golfers about Lyme disease and providing tips for preventing tick bites .

Key Points:

PORTOLA VALLEY, Calif., July 15, 2021 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the US, and the American Junior Golf Association have announced a new partnership aimed at educating young golfers about Lyme disease and providing tips for preventing tick bites .
In addition, Bay Area Lyme Foundation will become a Leadership Links charity partner, and two tournaments will be named for the Foundation by the end of 2023.
Knowing the symptoms of Lyme disease is critical as the current "gold standard" diagnostic for Lyme disease misses up to 60% of cases of early-stage Lyme disease.
Bay Area Lyme Foundation , a national organization committed to making Lyme disease easy to diagnose and simple to cure, is the leading public not-for-profit sponsor of innovative Lyme disease research in the US.A 501c3 non-profit organization based in Silicon Valley, Bay Area Lyme Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease.

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

Retrieved on:

Tuesday, July 6, 2021

Bacterial diseases, Tick-borne diseases, Medical specialties, Medicine, Neurodegenerative disorders, Bacteriology, Lyme disease, Allen Steere

PORTOLA VALLEY, Calif., July 6, 2021 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the U.S., announces the recipients of the 2021 Emerging Leader Awards (ELA), which are designed to support promising scientists who represent the future of Lyme disease research leadership.

Key Points:

PORTOLA VALLEY, Calif., July 6, 2021 /PRNewswire/ -- Bay Area Lyme Foundation , a leading sponsor of Lyme disease research in the U.S., announces the recipients of the 2021 Emerging Leader Awards (ELA), which are designed to support promising scientists who represent the future of Lyme disease research leadership.
Two of the award winners will utilize biological samples from the Lyme Disease Biobank , a program of the Bay Area Lyme Foundation, to collect well-characterized human tissue, blood and urine specimens to accelerate research of Lyme disease and other tick-borne infections.
Bay Area Lyme Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease.
The Lyme Disease Biobank (LDB), a program of the Bay Area Lyme Foundation, is working to accelerate research of Lyme disease and other tick-borne infections.

Global Lyme Alliance Launches Lyme Disease Awareness Month Campaign Focused on #Lymefacts and the Patient Experience

Retrieved on:

Friday, April 30, 2021

Bacterial diseases, Tick-borne diseases, Medical specialties, Neurodegenerative disorders, Medicine, Lyme Disease Awareness Month, Bacteriology, Lyme disease, Lyme, Connecticut, Tick-Borne Disease Alliance, Allen Steere

b'STAMFORD, Conn., April 30, 2021 /PRNewswire-PRWeb/ -- Global Lyme Alliance (GLA), the largest 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education, and patient services, launches its new Lyme Disease Awareness Campaign for May in recognition of Lyme Disease Awareness Month.\nThe campaign titled #LymeFacts is designed to bring attention to the unknown facts and truths of Lyme disease, the difficulties faced by patients living with the disease, and the often-confusing information among the general community.

Key Points:

b'STAMFORD, Conn., April 30, 2021 /PRNewswire-PRWeb/ -- Global Lyme Alliance (GLA), the largest 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education, and patient services, launches its new Lyme Disease Awareness Campaign for May in recognition of Lyme Disease Awareness Month.\nThe campaign titled #LymeFacts is designed to bring attention to the unknown facts and truths of Lyme disease, the difficulties faced by patients living with the disease, and the often-confusing information among the general community.
"We must educate the public at large so that more understand the truth about Lyme disease.
It is estimated that there are approximately 500,000 new cases of Lyme in the U.S. each year, with more than two million suffering from post-treatment Lyme disease.
Learn more and get involved at https://globallymealliance.org .\nGlobal Lyme Alliance (GLA) is the leading 501(c)(3) dedicated to conquering Lyme disease through research, education, and patient services.

New LymeNow Website Reminds Everyone Bella Hadid Isn't the Only One with Lyme

Retrieved on:

Thursday, April 29, 2021

Medicine, Bacterial diseases, Tick-borne diseases, Lyme Disease Awareness Month, Chronic Lyme disease, Lyme disease, Medical specialties, Medical ethics, Chronic condition, Lyme, Connecticut, Allen Steere

b"HARTFORD, Conn., April 29, 2021 /PRNewswire-PRWeb/ -- LymeNow is excited to announce the launch of a new website --just in time for May, Lyme Disease Awareness Month.

Key Points:

b"HARTFORD, Conn., April 29, 2021 /PRNewswire-PRWeb/ -- LymeNow is excited to announce the launch of a new website --just in time for May, Lyme Disease Awareness Month.
In the Lyme community, the number of Lyme cases is grossly underreported, and misinformation is widely accepted by the masses.\nLymeNow.com provides a place to learn the truth about Lyme disease, read Lyme disease news articles, watch stories of people living with Lyme, share treatments that work, and to contact the LymeNow support group.
And for those who do not have Lyme, learning how to prevent and/or detect Lyme symptoms could save your life.\nDuring Lyme Disease Awareness Month, attention and receptiveness to Lyme disease increase exponentially.
This is the best time to promote accurate information about Lyme disease and to amplify the voices of the Lyme community.\nLymeNow is a community of individuals living with chronic Lyme disease.

Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate

Retrieved on:

Monday, March 8, 2021

Medical specialties, Medicine, Vaccines, Health care, Vaccination, Vaccine, Virology, Valneva SE, Lyme disease, COVID-19 vaccine, Allen Steere

We are excited to be part of the Lyme disease vaccine development program with Valneva.

Key Points:

We are excited to be part of the Lyme disease vaccine development program with Valneva.
Including a pediatric population in Phase 2 means we could, if successful, add this population to the Phase 3 research program, to potentially offer a vaccine for Lyme disease that may help prevent disease in both adults and children, if approved.
VLA15 is the only active Lyme disease vaccine candidate in clinical development today, and covers six serotypes that are prevalent in North America and Europe.
This investigational multivalent protein subunit vaccine targets the outer surface protein A (OspA) of Borrelia, an established mechanism of action for a Lyme disease vaccine.

NPMA Emphasizes Tick Prevention Amidst New CDC Lyme Disease Estimates

Retrieved on:

Wednesday, January 27, 2021

Family, Health, Consumer, Women, General Health, MEN, Tick-borne diseases, Ticks, Medical specialties, Zoonoses, Bacterial diseases, Neurodegenerative disorders, Lyme disease, Tick-borne disease, Allen Steere, Occupational exposure to Lyme disease

According to new research released by the Centers for Disease Control and Prevention ( CDC ), human cases of tickborne Lyme disease are more common in the U.S. than previously thought.

Key Points:

According to new research released by the Centers for Disease Control and Prevention ( CDC ), human cases of tickborne Lyme disease are more common in the U.S. than previously thought.
Although Lyme disease is treatable, it can easily be confused for other conditions and cases of the disease are vastly underreported.
In addition to aiding in Lyme disease diagnosis, regular tick checks can actually help prevent disease transmission in the first place.
Lyme disease can be transmitted into a persons bloodstream in as little as 36-48 hours after the initial tick bite, making prompt detection and proper tick removal key to disease prevention.

Valneva Announces Acceleration of Pediatric Development for Lyme Disease Vaccine Candidate

Retrieved on:

Wednesday, December 2, 2020

Medical specialties, Vaccines, Medicine, Clinical medicine, Vaccine, Virology, Lyme disease, Vaccination, Allen Steere, Lyme disease microbiology

VLA15 is the only active Lyme disease vaccine in clinical development today, and covers six serotypes that are prevalent in North America and Europe.

Key Points:

VLA15 is the only active Lyme disease vaccine in clinical development today, and covers six serotypes that are prevalent in North America and Europe.
This investigational multivalent protein subunit vaccine targets the outer surface protein A (OspA) of Borrelia, an established mechanism of action for a Lyme disease vaccine.
The medical need for vaccination against Lyme disease is steadily increasing as the disease footprint widens8.
The Company has several vaccines in development including vaccines against Lyme disease, COVID-19 and chikungunya.

UMD Spearheads the Development of a Novel Lyme Disease Vaccine, Leading a New $3.5 Million Grant

Retrieved on:

Wednesday, August 19, 2020

Medical specialties, Medicine, Infectious diseases, RTT, Lyme disease, Vaccine, Rabies vaccine, Rabies, Allen Steere

Addressing the need for an effective Lyme disease vaccine to prevent the upwards of 300,000 new cases in the U.S. alone each year and reduce the burden of chronic or post-treatment Lyme disease, the University of Maryland (UMD) is leading a new $3.5 million grant from the National Institutes of Health (NIH) to develop a novel "next-generation" Lyme disease vaccine.

Key Points:

Addressing the need for an effective Lyme disease vaccine to prevent the upwards of 300,000 new cases in the U.S. alone each year and reduce the burden of chronic or post-treatment Lyme disease, the University of Maryland (UMD) is leading a new $3.5 million grant from the National Institutes of Health (NIH) to develop a novel "next-generation" Lyme disease vaccine.
The only way to prevent this is to prevent Lyme, and a vaccine is a good answer for that," says Pal.
"We are using the rabies virus as a delivery platform to send in some vaccine candidates for Borrelia," explains Pal.
This includes testing not only the four candidate proteins, but also three major types of rabies vaccine platforms that could be effective for Lyme disease.

National Study Finds Lyme Disease 10 Times Greater Than Reported to CDC; Quidel-Sponsored Webinar Reveals Prevalence and Patterns of Lyme Disease

Retrieved on:

Wednesday, August 19, 2020

The clinical study tracked the testing of 5.2 million people from throughout the United States and found that as many as 300,000 Americans contract Lyme disease each year.

Key Points:

The clinical study tracked the testing of 5.2 million people from throughout the United States and found that as many as 300,000 Americans contract Lyme disease each year.
It further found that Lyme disease occurs in all age groups, in all regions of the country and shows no particular preference for gender.
The study was conducted by Elizabeth Lee-Lewandrowski, Ph.D., MPH, a national key opinion leader on tick-borne diseases, in conjunction with her collaborators ( https://academic.oup.com/ajcp/article/152/1/91/5461358 ).
Other key findings of the landmark study include:
As suspected, Lyme disease has a seasonal peak in June, July and August.

It's Lyme Disease Season: 'Be on Guard and Get Tested' Says Leading Health Solutions Developer Quidel Corporation

Retrieved on:

Tuesday, August 11, 2020

Infectious diseases, Medical specialties, Medicine, Bacterial diseases, Tick-borne diseases, RTT, Lyme disease, Allen Steere

"With appropriate antibiotic treatment, most people with Lyme disease recover completely; but the key is catching it early, and that means not hesitating to get tested."

Key Points:

"With appropriate antibiotic treatment, most people with Lyme disease recover completely; but the key is catching it early, and that means not hesitating to get tested."
Since symptoms such as these are so common, doctors don't always think of Lyme disease right away, but you should.
If you sense that you might have Lyme disease, get to your doctor and ask to be tested right away.
Leading the way in Lyme disease testing is the innovative Sofia 2 Lyme FIA test.